http://www.hepnet.com/hkn/b11.html
|
|
The
Hepatitis Information Network
Hepatitis |
|
|
Original Paper
The Newsletter is supported by an educational grant from Schering Canada Inc. and GlaxoWellcome Canada.
Hepatitis B:The Complexities
Hepatitis B: A Brief History: In 1965, Dr. Blumberg who was studying haemophilia, found an antibody in two patients which reacted against an antigen from an Australian Aborigine. Later the antigen was found in patients with serum type hepatitis and was initially designated "Australian Antigen". Subsequent study has shown the Australia Antigen to be the hepatitis B surface antigen. Dr. Blumberg was subsequently awarded the Nobel Prize for his discovery. Initially there appeared to be three particles associated with hepatitis B infection: a large "complete" particle called the "Dane particle", a small circular 20nm particle and an oblong 40nm particle. Further research identified the Dane particle as the hepatitis B viron and the other two particles as excess surface protein. This former terminology is no longer used and the virus is referred to according to its structure. Hepatitis B Virus: A Complex Structure The hepatitis B viron consists of a surface and a core. The core contains a DNA polymerase and the e antigen. The DNA structure is double stranded and circular. There are four major polypeptide reading frames (genes): the S (surface), the C (core), the P (polymerase) and the X (transcriptional transactivating). The S gene consists of three regions, the pre-S1, pre-S2 and encodes the surface proteins (HBsAg). Very rarely a mutation may occur in the S gene and may abort the HBsAg with the result that a person may be HBsAg negative but still have virus present as determined by HBV DNA. The C gene is divided into two regions, the pre-core and the core, and codes for two different proteins, the Core antigen (HBcAg) and the e antigen (HBeAg). A not uncommon mutant is the pre-core mutant, which may stop production of HBeAg, and these persons will be HBsAg positive, HBV DNA positive, but HBeAg negative. A third mutant which appears to have a mutant in the core has been described and is referred to as HBV2. These patients are HBsAg positive, but lack HBeAg and HBV DNA, thus also anti-HBc. Another mutant, the YMDD mutant, will be described at a later date. To make it even more complex, the HBsAg particles are antigenically complex and these antigenic determinants have been identified. There is a single common determinant designated a, and four major subdeterminants designated d,y,w and r. Thus, the four major determinants are: adw, adr, ayw and ayr. Multiple Tests are Available Because of the complexity and the antigenic differences of the virus, there are a number of tests available for hepatitis B: Antigens Antibodies Other Markers Hep B:The Complexities Carrier Rates Vary Greatly Carrier rates for hepatitis B vary enormously: Country and Carrier rate%: High Infectivity Hepatitis B DNA is found in many body fluids including saliva, urine, semen and menstrual blood. It has also been shown that the virus can be transmitted by ingesting contaminated blood. Hence, hepatitis B may be transmitted by: » mother to infant at the time of birth Extra-Hepatic Associations Although uncommon, a number of conditions associated with hepatitis B antigen/antibody complexes have been recognized. These include: Polyarteritis - usually involves medium and small arteries, appears early |
|
Webmaster@hepnet.com HepNet developed by Michael Betel, Copyright © 1995-2000 Schering Canada Inc. 3535 Trans-Canada Highway, Pointe Claire, Quebec H9R 1B4 |
||
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.